Location Dallas, Texas, United States Regions Dallas/Fort Worth Metroplex, Southern US Gender Male
Investor Type
LinkedIn View on LinkedIn
Managing Partner and Co-Founder of Latticework Capital Management, LLC.
Kyle Bradford joined American Capital in March 2002 and is a Managing Director in the Dallas Buyout Group. He is responsible for originating, executing and managing investments in middle-market companies across a variety of industry sectors, including life science services,
medical device, medical tools and equipment, and healthcare services, among others. Additionally, he is responsible for American Capital’s investment effort in healthcare royalties and healthcare royalty finance.
Mr. Bradford currently is chairman of American Capital portfolio companies CML Pharmaceuticals and and ECA Medical, serves on the board of directors of The Meadows and DynoJet, and is a board observer of Scientific Protein Laboratories. He was previously chairman of Value Plastics and on the board of directors of Hospitality Mints, Future Food and Unwired Technology.
Prior to joining American Capital, Mr. Bradford worked in the Technology Investment Banking Division of Salomon Smith Barney in New York. At Salomon, Mr. Bradford specialized in equity and debt underwriting and merger and acquisition advisory assignments for companies in various technology sectors. Before Salomon, he worked in the Syndicated Finance Group of Banc of America Securities in New York.
Mr. Bradford received a Masters in Professional Accounting and a Bachelors of Business Administration from the University of Texas at Austin. He is currently on the Advisory Board of the College of Pharmacy at the University of Texas at Austin.
